Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhGH for short stature in late adolescent children
ChiCTR2100043880Phase 4Recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of somatropin in growth disorder (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Height, Growth velocity (CV) and 4 more. Started Jun 2021; status: recruiting.
02
Drugs
somatropin
03
Conditions
growth disorder
Beyond the preview
Go deeper on ChiCTR2100043880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043880.